Seasonal flu epidemic in the Netherlands The flu epidemic in the Netherlands has started. The number of people with flu (influenza) increased significantly in the past two weeks.
Flu epidemic seems to be emerging More and more people in the Netherlands have the flu. The number of people with flu increased significantly last week.
RIVM calls for increased involvement of scientific community in solving plastic crisis Industry and policymakers are not availing themselves enough of the available scientific knowledge when it comes to smarter ways of dealing with plastics.
Significant increase in support for and compliance with coronavirus measures Compliance with coronavirus measures such as working from home, distancing and testing if you have symptoms increased during the recent period of high infection rates and hospital admissions.
Wider availability of self-tests leads to higher willingness to test As of Friday 3 December, the recommendation in the Netherlands is to use a self-test in case of mild symptoms, as an alternative to a test by the Municipal Public Health Services (GGDs). Beeld: ANP
Better monitoring of RSV thanks to new European project RIVM and Nivel contribute to building a European RSV monitoring network. Through the network, European health institutions and laboratories will exchange data on the spread of RSV. This will help us to better monitor the virus.
Compliance with coronavirus measures requires attention Compliance with coronavirus measures such as working from home, distancing and testing if you have symptoms decreased in the weeks leading up to the Cabinet’s recent press conference.
RIVM magazine special edition on Climate Change and Health The RIVM Magazine special edition on Climate change and Health showcases the scope of RIVM’s work on this topic.
More than health risks play a role in compliance with coronavirus measures The risk of COVID-19 is not the only factor that determines compliance with the coronavirus measures; other risks also play a role.
Flu jab for additional groups The flu jab is offered free of charge every year to people aged 60 years and older, and to people who are at higher risk of becoming seriously ill from the flu virus due to medical reasons